Your browser doesn't support javascript.
loading
Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally advanced pancreatic cancer patients.
Ingram, Myles A; Lauren, Brianna N; Pumpalova, Yoanna; Park, Jiheum; Lim, Francesca; Bates, Susan E; Kastrinos, Fay; Manji, Gulam A; Kong, Chung Yin; Hur, Chin.
Afiliación
  • Ingram MA; Division of General Medicine, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Lauren BN; Division of General Medicine, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Pumpalova Y; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Park J; Division of General Medicine, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Lim F; Division of General Medicine, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Bates SE; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.
  • Kastrinos F; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.
  • Manji GA; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Kong CY; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.
  • Hur C; Division of General Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Cancer Rep (Hoboken) ; 5(9): e1565, 2022 09.
Article en En | MEDLINE | ID: mdl-35122419
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos